Bill & Melinda Gates Foundation, WeDoctor, and DXY Join Forces as 'Healthcare Partners' in Innovation Competition

Since the registration launched on December 22, 2015, the “Medical Partnership Innovation Cooperation Scheme Competition,” themed “Growing Together in Healthcare, Winning Through Collaboration” and hosted by Pfizer, Ping An Insurance, Tencent, and Legend Capital, has garnered enthusiastic support from entrepreneurs, with over 200 startups having registered to date.

The competition has also drawn significant attention from the entire healthcare industry. Recently, the organizing committee announced that, to better provide participating teams with resources and collaboration opportunities, it has invited the Bill & Melinda Gates Foundation (hereinafter referred to as the “Gates Foundation”), the world’s largest foundation, as the public welfare and charitable partner of the competition. It has also invited WeDoctor Group and DXY, leading enterprises in China’s internet healthcare sector, as strategic partners. In addition to negotiating collaborations with the four organizers—Pfizer, Ping An, Tencent, and Legend Capital—outstanding participating teams may choose to engage in in-depth exchanges with the competition’s partners, based on their respective interests and development directions.

Why Is the Gates Foundation Becoming a “Healthcare Partner”?
Solving China's Healthcare Challenges with a Global Perspective


Guided by the belief that “all lives have equal value,” the Bill & Melinda Gates Foundation has been committed to helping developing countries improve health outcomes and overcome hunger and poverty.

The Bill & Melinda Gates Foundation was established in January 2000 by Microsoft co-founder Bill Gates and his wife, Melinda Gates. Since its inception, the foundation has disbursed a total of $33.5 billion in grants, making it the largest foundation in the world.

The Bill & Melinda Gates Foundation has been committed to harnessing the power of public and private partners to jointly build an innovative health ecosystem. It actively develops and provides vaccines, medicines, diagnostic reagents, and other high-quality, affordable health solutions for developing countries, striving to save lives in these nations through technological innovation.

Dr. Wu Wenda, Deputy Director of the Bill & Melinda Gates Foundation’s Beijing Representative Office, pointed out that while the Foundation sincerely appreciates the achievements China has made in its healthcare sector over the past few decades, the country still faces formidable challenges. For instance, in terms of tuberculosis (TB) prevention and control, China remains one of the countries with the highest TB burden globally. The continuous emergence of a large number of drug-resistant TB cases places immense pressure on the public health system. Furthermore, discrepancies between China’s regulatory framework for pharmaceutical products and international standards have, to some extent, hindered the rapid entry of vaccines and medicines developed and manufactured in China into international markets or the procurement systems of international organizations.

To address these challenges, the Bill & Melinda Gates Foundation has launched a series of extensive and significant collaborations with China’s healthcare system, such as the “Grand Challenges China” program in partnership with the National Natural Science Foundation of China, and the jointly established “Global Health Drug Discovery Institute (Beijing)” with Tsinghua University, among others.

Regarding the Medical Partner Innovation Competition, Dr. Wu Wenda believes that the competition’s mission aligns perfectly with the Bill & Melinda Gates Foundation’s focus on investing in health innovation and building ecosystems. The Foundation is confident that the Medical Partner Innovation Competition will provide a launchpad for internet-based healthcare, accelerating the commercialization of innovative technologies and R&D achievements. Furthermore, the Gates Foundation hopes to identify like-minded partners through this competition to jointly initiate collaborative projects addressing health challenges faced by impoverished populations.

The Gates Foundation’s ultimate expectation for this Medical Partners Innovation Competition is that it will not only benefit the Chinese people, but also propel China’s innovative medical products and technologies onto the global stage, bringing benefits to people in other developing countries.

Resources Provided by the Gates Foundation to Participating Companies:
1. Bring to startups extensive experience in collaborating with leading global and Chinese medical R&D institutions, international organizations, investment firms, and pharmaceutical companies, ensuring that innovative achievements benefit those most in need;
2. Infuse startups with the influence and expertise of key players in the global healthcare ecosystem, working together with these stakeholders to drive transformation in China’s healthcare industry.

Why Does WeDoctor Group Want to Be a "Medical Partner"?
Leveraging Internet Thinking to Build a Complete Healthcare Industry Chain Integrating Medical Services, Insurance, and Pharmaceuticals

 


WeDoctor Group, as China’s largest internet healthcare platform, aims to fundamentally address the major challenge of “difficulty in accessing medical care” in the country.

WeDoctor Group is committed to connecting hospitals, doctors, and patients through the internet. Looking ahead, WeDoctor Group has an even more ambitious blueprint. The group plans to raise $300 million to train 1 million primary care physicians, establishing a new diagnosis and treatment model featuring “general practitioners + specialist experts.” Additionally, it will raise $150 million to build five regional surgical centers across China, creating a “National Internet-Based Tiered Diagnosis and Treatment Platform.” Building on its existing base of over 2 million health insurance users, WeDoctor Group will launch the WeDoctor “Accountable Care Organization” (WeDoctor ACO) plan, providing convenient and efficient medical and healthcare services to hundreds of millions of families.

Micro Medical Group expressed its honor in becoming a strategic partner of the competition, hoping to leverage this opportunity to engage in in-depth exchanges with partners who share its vision, thereby further improving the healthcare experience for patients and the working conditions for doctors.

WeDoctor aims to partner with Pfizer to help patients develop consistent medication habits and improve drug adherence. WeDoctor and Ping An can jointly explore the establishment of a comprehensive “Internet + Healthcare + Insurance” ecosystem to provide stronger support for online diagnosis and treatment. Regarding its investor Tencent, WeDoctor seeks to collaborate closely to optimize its internet hospital platform, striving for leadership both in China and globally in terms of user base and technological capabilities. Additionally, through this event, WeDoctor hopes to deepen mutual understanding and explore cooperation with Legend Capital, which has extensive experience in healthcare investments, to jointly address the challenges of accessing medical care in China.

For participating companies, WeDoctor, as an open internet healthcare platform, is more inclined to support deep-dive startup projects focused on specific disease verticals and precision medicine initiatives. We look forward to these projects collaborating on the WeDoctor platform to jointly build a thriving internet healthcare ecosystem.

Resources Provided by WeDoctor Group to Participating Enterprises:
1. Provide entrepreneurship guidance: Offer mobile health startup guidance to participating companies and share WeDoctor’s entrepreneurial experience;
2. Resource Matching: Provide outstanding participating companies with traffic needs access to WeDoctor platform resources;
3. Preferential Support Policies: WeDoctor provides outstanding startups with preferential policies related to settlement in the WeDoctor Entrepreneurship Industrial Park, taxation, and other benefits;
4. Financial Support: Outstanding startups with financing needs may explore opportunities to secure investment from WeDoctor.

Why Does DXY Want to Be a "Medical Partner"?
Collaboratively Driving Healthcare Industry Transformation from an Industrial Landscape Perspective


Over the past 16 years since its establishment, DXY has been committed to building a professional academic exchange platform for physicians, providing patients with science-based health education, and improving the healthcare environment.

Since its founding 16 years ago, DXY has been deeply engaged with the Chinese physician community and is currently the largest and most influential social media platform in the healthcare industry. DXY aims to establish a professional academic exchange platform for physicians, provide patients with science-based health education, and improve the medical care environment.

DXY has a profound understanding of China’s healthcare sector and the landscape of its medical industry. DXY believes that the fundamental root cause of the difficulties and high costs associated with accessing medical care in China lies in the uneven distribution of medical resources, which has resulted in medical supply falling far short of demand. However, the continued advancement of policies such as tiered diagnosis and treatment and multi-site practice, coupled with the continuous influx of social capital into the healthcare sector and an increasingly robust entrepreneurial ecosystem across society, have provided excellent opportunities to address the imbalance between medical supply and demand in China.

Against this backdrop, DXY believes that the Medical Partner Innovation Competition is timely, bringing together leading enterprises from various sectors such as healthcare, internet, and finance, thereby providing excellent opportunities for resource alignment among all parties. DXY will also leverage its advantageous resources to actively support startups.

DXY places high hopes on its collaboration with the competition organizers—Pfizer, Ping An Insurance, Tencent, and Legend Capital. DXY looks forward to leveraging the unique insights and extensive experience of leading enterprises across various sectors. Against the backdrop of the evolving healthcare industry landscape, it aims to focus on exploring new business models in areas such as physician engagement, chronic disease management, and offline clinics, thereby jointly driving transformation and development in the healthcare sector.

Resources Provided by DXY for Participating Enterprises:
1. Sharing Entrepreneurial Experience: Insights from DXY’s 15 Years in Healthcare Internet—How to Identify User Needs and Design Products;
2. Project/Team Incubation: End-to-end coaching for entrepreneurship, project development, and product planning;
3. Professional User Resources: Over the course of its development, DXY has accumulated China’s largest online community of healthcare professionals. Opening up this resource, while fully safeguarding user privacy, is a worthwhile and valuable endeavor. We will leverage DXY’s resources to address the cold-start challenges faced by many projects.
4. Media Resources: As the most influential media platform in the healthcare industry, we provide comprehensive brand support for innovative teams and projects;
5. Technical personnel and office space.

Driven by a shared vision for the future of healthcare in China and inspired by the competition’s original mission to advance the nation’s medical system and deliver high-quality healthcare services to its citizens, the Bill & Melinda Gates Foundation, WeDoctor Group, and DXY have actively joined this initiative. Together with the event organizers—Pfizer, Ping An Insurance, Tencent, and Legend Capital—they will leverage their global perspectives, cross-sector resources, and deep industry expertise to provide participating teams with comprehensive support and abundant resources. This competition is poised to offer an optimal platform for innovative startups and inject vibrant momentum into the robust development of China’s healthcare sector.

—————Divider Requiring High Attention—————

Over 200 companies have already registered. The registration deadline for this competition is February 13. Time waits for no one, so please participate immediately based on the guidelines provided by VCBeat. The registration link is posted again below.

http://www.cyzone.cn/features/hcpartners/

You can also scan the QR code below to follow VCBeat. Simply send us a message with your inquiries, and the VCBeat team will provide comprehensive and enthusiastic responses.